Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Internal Medicine (Tokyo, Japan)|November 5, 2010
Atrioventricular block and diastolic dysfunction in a patient with Sanfilippo CIkuo Misumi, Shoji Chikazawa, Takateru Ishitsu, et al.
Plos One|October 21, 2015
Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic AnalysisHiroo Nakashima, Kentaro Oniki, Miki Nishimura, et al.
Plos One|November 6, 2014
Impact of the superoxide dismutase 2 Val16Ala polymorphism on the relationship between valproic acid exposure and elevation of γ-glutamyltransferase in patients with epilepsy: a population pharmacokinetic-pharmacodynamic analysisNaoki Ogusu, Junji Saruwatari, Hiroo Nakashima, et al.
Neuropsychiatric Disease and Treatment|April 22, 2015
Possible association between moderate intellectual disability and weight gain in valproic acid-treated patients with epilepsyYukiko Tanamachi, Junji Saruwatari, Madoka Noai, et al.
Pharmacogenetics and Genomics|January 4, 2014
Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinductionJunji Saruwatari, Shiho Yoshida, Yoshiyuki Tsuda, et al.
Epilepsy Research|November 29, 2011
Superoxide dismutase 2 Val16Ala polymorphism is a risk factor for the valproic acid-related elevation of serum aminotransferasesJunji Saruwatari, Mariko Deguchi, Yuki Yoshimori, et al.
Therapeutic Drug Monitoring|December 19, 2013
Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in japanese patients with epilepsyJunji Saruwatari, Naoki Ogusu, Masatsugu Shimomasuda, et al.
Pharmacogenomics|March 15, 2014
ABCC2 rs2273697 and rs3740066 polymorphisms and resistance to antiepileptic drugs in Asia Pacific epilepsy cohortsHidayati Mohd Sha'ari, Batoul Sadat Haerian, Larry Baum, et al.
Pageof 2